EUVIMEDEUVIMED entdecken
Multizentrische Studie

Application of the International System for Serous Fluid Cytopathology in cerebrospinal fluid cytology: Overall survival analysis associated with diagnostic categories

Isil Z Yildiz Aktas, Baidarbhi Chakraborty iD, Jia Meng Zhang, Yuan Wang, Jocelyn Chandler iD, Carlos Mauricio Mejia Arbelaez, Maximilian Wegener, Travis Blake Fenlon, Abdol Aziz Ould Ismail, Jonathan D Marotti iD, Zhihui Zhang, Xiaoying Liu und 1 weitere

Cancer Cytopathology · 2026-07 · 134 (7)

DOI: 10.1002/cncy.70127 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Cytopathology, online erschienen am 21.06.2026. Verfasst von Isil Z Yildiz Aktas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Cytodiagnosis, Cerebrospinal Fluid, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebrospinal fluid (CSF) cytopathology lacks standardized reporting, leading to diagnostic variability and inconsistent clinical management. Although the International System for Reporting Serous Fluid Cytopathology (TIS) has been established for effusions, its utility in CSF remains underexplored. For this study, the authors applied TIS categories to CSF specimens from three academic centers across two continents and evaluated their association with overall survival (OS).

Methods

A retrospective review of pathology databases (2019–2022) across three institutions was performed. Data included demographics, cytologic diagnosis, and OS. Diagnoses were reclassified using TIS criteria. OS was analyzed using Kaplan–Meier curves and Cox proportional hazards models, and multivariable analysis was used for predictors of mortality.

Results

In total, 1137 patients underwent CSF cytologic evaluation. Diagnostic distribution was as follows: 3.2% nondiagnostic, 67.1% negative for malignancy, 6.2% atypia of undetermined significance, 2.7% suspicious for malignancy, and 20.8% malignant. Among 579 patients with follow‐up, OS differed across categories ( p < .001). Mean survival was longest in patients who were diagnosed as negative for malignancy (53.9 months), followed by atypia of undetermined significance (48.4 months), and suspicious for malignancy (40.3 months), and it was shortest in patients who were diagnosed with malignancy (18.7 months).

Conclusions

Leveraging a large, multi‐institutional cohort with up to 5 years of follow‐up, this study demonstrated that TIS categories effectively stratify CSF specimens into distinct prognostic groups. The authors identified a significant correlation between diagnostic classification and OS, with a clear decline in patient outcomes from those who had diagnoses of negative for malignancy/atypia of undetermined significance to those who had diagnoses of suspicious for malignancy and malignancy. These findings support the TIS system as a standardized, evidence‐based framework that enhances risk stratification and clinical decision‐making in CSF cytopathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytodiagnosisCerebrospinal FluidNeoplasmsHumansFemaleRetrospective StudiesMaleMiddle AgedPrognosisAgedSurvival AnalysisAdult

Stichwörter der Autor:innen

cerebrospinal fluid (CSF)cytologyoverall survivalthe International System for Reporting Serous Fluid Cytopathology (TIS)

Autor:innen und Institutionen

  • Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Pathology, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.
  • Department of Pathology, St Clare's Hospital, Denville, New Jersey, USA.
  • Department of Cytopathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Department of Pathology and Laboratory Medicine, Stony Brook University School of Medicine, Stony Brook, New York, USA.

ORCID-Profile: Baidarbhi Chakraborty, Jocelyn Chandler, Jonathan D Marotti

Zitieren

APA

Yildiz Aktas, I. Z., Chakraborty, B., Zhang, J. M., Wang, Y., Chandler, J., Mejia Arbelaez, C. M., Wegener, M., Fenlon, T. B., Ould Ismail, A. A., Marotti, J. D., Zhang, Z., Liu, X., & Wang, H. (2026). Application of the International System for Serous Fluid Cytopathology in cerebrospinal fluid cytology: Overall survival analysis associated with diagnostic categories. Cancer Cytopathology, 134(7). https://doi.org/10.1002/cncy.70127

Vancouver

Yildiz Aktas IZ, Chakraborty B, Zhang JM, Wang Y, Chandler J, Mejia Arbelaez CM, et al. Application of the International System for Serous Fluid Cytopathology in cerebrospinal fluid cytology: Overall survival analysis associated with diagnostic categories. Cancer Cytopathology. 2026;134(7). doi:10.1002/cncy.70127

BibTeX
@article{YildizAktas2026,
  author = {Yildiz Aktas, Isil Z and Chakraborty, Baidarbhi and Zhang, Jia Meng and Wang, Yuan and Chandler, Jocelyn and Mejia Arbelaez, Carlos Mauricio and Wegener, Maximilian and Fenlon, Travis Blake and Ould Ismail, Abdol Aziz and Marotti, Jonathan D and Zhang, Zhihui and Liu, Xiaoying and Wang, He},
  title = {Application of the International System for Serous Fluid Cytopathology in cerebrospinal fluid cytology: Overall survival analysis associated with diagnostic categories},
  journal = {Cancer Cytopathology},
  year = {2026},
  volume = {134},
  number = {7},
  doi = {10.1002/cncy.70127}
}
Kostenlos starten →